Inovio Pharmaceuticals has cut staff and narrowed its focus to its lead rare disease candidate, which is already encountering early FDA pushback. The company reported 112 employees as of March 11, down from 134 a year earlier.
https://www.fiercebiotech.com/biotech/inovio-trims-team-trouble-brews-fda-rare-disease-candidate